Development and implementation of a comprehensive heparin-induced thrombocytopenia recognition and management protocol

American Journal of Health-System Pharmacy

Volumn 69, Issue 3, 2012, Pages 241-248

  Smythe, Maureen A ^a,b   Mehta, Trupti P ^a,b   Koerber, John M ^a,b   Forsyth, Lisa L ^a,b   Sykes, Elizabeth ^c   Corbets, Lindsey R ^b   Melendy, Susan M ^c   Parikh, Rajul ^c  

^a WAYNE STATE UNIVERSITY   (United States)

^b BEAUMONT HOSPITAL   (United States)

^c BH ^*  (United States)

Author keywords

Anticoagulants; Argatroban; Documentation; Dosage; Economics; Heparin; Hospitals; Joint Commission on Accreditation of Healthcare Organizations; Lepirudin; Patient information; Pharmaceutical services; Pharmacists, hospital; Pharmacy, institutional, hospital; Prescribing; Protocols; Quality assurance; Records; Standards; Thrombocytopenia; Toxicity

Indexed keywords

ARGATROBAN; HEPARIN; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; THROMBIN INHIBITOR; WARFARIN;

ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CLINICAL PROTOCOL; COST EFFECTIVENESS ANALYSIS; ELECTRONIC MEDICAL RECORD; ENZYME LINKED IMMUNOSORBENT ASSAY; HEALTH CARE POLICY; HEALTH CARE PRACTICE; HEALTH CARE QUALITY; HEPARIN INDUCED THROMBOCYTOPENIA; HEPARINIZATION; HUMAN; MEDICAL DOCUMENTATION; MEDICAL INFORMATION; NEEDS ASSESSMENT; NURSE; PARTIAL THROMBOPLASTIN TIME; PATIENT EDUCATION; PATIENT INFORMATION; PATIENT MONITORING; PHARMACIST; PHYSICIAN; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; TOTAL QUALITY MANAGEMENT;

EID: 84857556765     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp110313     Document Type: Article

References (14)

1. Bratzler DW. Development of national performance measures on the prevention and treatment of venous thromboembolism. J Thromb Thrombolysis. 2010; 29:148-54.
2. Joint Commission. Accreditation program: hospital national patient safety goals. NPSG.03.05.01. Reduce the likelihood of patient harm associated with the use of anticoagulant therapy. www.jointcommission.org/ NR/rdonlyres/868C9E07- 037F-433D- 8858-0D5FAA4322F2/0/Rev i s ed Chapter-HAP-NPSG-20090924.pdf (accessed 2010 Jan 5).
3. Warkentin TE, Greinacher A, Koster A et al. Treatment and prevention of heparininduced thrombocytopenia: American College of Chest Physicians evidencebased clinical practice guidelines (8th edition). Chest. 2008; 133:340s-380s. [Erratum. Chest. 2011; 139:1261.] (Pubitemid 351892970)
4. Schulman S, Beyth RJ, Kearon C et al. Hemorrhagic complications of anticoagulant and thrombolytic treatment, American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008; 133:257s-298s. (Pubitemid 351892969)
5. Nguyen MN, Koerber JM, Smythe MA. Comparison of argatroban dosing techniques: nomogram versus non-nomogram directed therapy. http: //glprc.com/files/abstracts2008.pdf (accessed 2011 May 3).
6. Lo GK, Sigouin CS, Warkentin TE. What is the potential for overdiagnosis of heparin-induced thrombocytopenia? Am J Hematol. 2007; 82:1037-43. (Pubitemid 350209843)
7. Lo GK, Juhl D, Warkentin TE et al. Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost. 2006; 4:759-65.
8. Wang P, Koerber J, Smythe M. Impact of the 4T's scoring system and an IgG-specific ELISA on the potential to overdiagnose HIT. http://glprc.com/ files/abstracts2009.pdf (accessed 2011 May 3).
9. Smythe MA, Koerber JK, Forsyth LL et al. Argatroban dosage requirements and outcomes in intensive care versus nonintensive care patients. Pharmacotherapy. 2009; 29:1073-81.
10. Baldwin ZK, Spitzer AL, Ng VL. Contemporary standards for the diagnosis and treatment of heparin-induced thrombocytopenia. Surgery. 2008; 143:305-12.
11. Otis SA, Zehnder JL. Heparin-induced thrombocytopenia: current status and diagnostic challenges. Am J Hematol. 2010; 85:700-6.
12. Fugate S, Chiappe J. Standardizing the management of heparin-induced thrombocytopenia. Am J Health-Syst Pharm. 2008; 65:334-9. (Pubitemid 351294843)
13. Warkentin TE, Sheppard JI, Moore JC. Quantitative interpretation of optical density measurements using PF4- dependent enzyme-immunoassays. J Thromb Haemost. 2008; 6:1304-12. (Pubitemid 352016309)
14. Kiser TH, Mann AM, Trujillo TC. Evaluation of empiric versus nomogram based direct thrombin inhibitor management in patients with suspected heparin-induced thrombocytopenia. Am J Hematol. 2011; 86:267-72.